Rituximab Objective Outcome Measures Trial in SLE

Clinical trial NCT03054259 · UNKNOWN

Trial details

NCT number

NCT03054259

Sponsor

University of Leeds

Status

UNKNOWN

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-09-21

Primary completion

2020-02-01

Enrollment

30

View on ClinicalTrials.gov